OR

Browse By

Ketol-acid reductoisomerase: An important antituberculosis drug target (2018–2021)

Grant type:
NHMRC Project Grant
Researchers:

  • Professor Luke Guddat

    Professor
    School of Chemistry and Molecular Biosciences
    Faculty of Science

  • Professor Gary Schenk

    Professor
    School of Chemistry and Molecular Biosciences
    Faculty of Science
    Professor
    Australian Institute for Bioengineering and Nanotechnology

  • Associate Professor Nick West

    Associate Professor
    School of Chemistry and Molecular Biosciences
    Faculty of Science
Funded by:
National Health and Medical Research Council